Data:
{
"symbol": "CRL",
"price": 290.64,
"marketCap": 13999460328,
"beta": 1.405,
"lastDividend": 0,
"range": "145.32-303.31",
"change": -3.8,
"changePercentage": -1.29059,
"volume": 192800,
"averageVolume": 926139,
"companyName": "Charles River Laboratories International, Inc.",
"currency": "USD",
"cik": "0001100682",
"isin": "US1598641074",
"cusip": "159864107",
"exchangeFullName": "New York Stock Exchange",
"exchange": "NYSE",
"industry": "Medical - Diagnostics & Research",
"website": "https://www.criver.com",
"description": "Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.",
"ceo": "Birgit Girshick",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "19000",
"phone": "781 222 6000",
"address": "251 Ballardvale Street",
"city": "Wilmington",
"state": "MA",
"zip": "01887",
"image": "https://images.financialmodelingprep.com/symbol/CRL.png",
"ipoDate": "2000-06-23",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "CRL",
"name": "Charles River Laboratories International, Inc.",
"price": 293.655,
"changePercentage": -0.77882,
"change": -2.305,
"volume": 10592,
"dayLow": 293.455,
"dayHigh": 296.97,
"yearHigh": 303.31,
"yearLow": 146.2,
"marketCap": 14144685943,
"priceAvg50": 271.974,
"priceAvg200": 208.5381,
"exchange": "NYSE",
"open": 296.97,
"previousClose": 295.96,
"timestamp": 1790775303,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-19",
"v": 289.8384,
"c": 290
},
{
"t": "2026-08-20",
"v": 294.372,
"c": 291.45
},
{
"t": "2026-08-21",
"v": 295.3683,
"c": 295.19
},
{
"t": "2026-08-24",
"v": 296.1685,
"c": 298.58
},
{
"t": "2026-08-25",
"v": 298.1921,
"c": 297.64
},
{
"t": "2026-08-26",
"v": 296.033,
"c": 295.1
},
{
"t": "2026-08-27",
"v": 299.0312,
"c": 296.41
},
{
"t": "2026-08-28",
"v": 292.0737,
"c": 291.5
},
{
"t": "2026-08-31",
"v": 287.5007,
"c": 288.24
},
{
"t": "2026-09-01",
"v": 283.0835,
"c": 282.34
},
{
"t": "2026-09-02",
"v": 289.5062,
"c": 291.76
},
{
"t": "2026-09-03",
"v": 290.9812,
"c": 293.35
},
{
"t": "2026-09-04",
"v": 288.9671,
"c": 288.5
},
{
"t": "2026-09-08",
"v": 282.1397,
"c": 280.76
},
{
"t": "2026-09-09",
"v": 277.8326,
"c": 278.35
},
{
"t": "2026-09-10",
"v": 273.0436,
"c": 273
},
{
"t": "2026-09-11",
"v": 278.0177,
"c": 278.26
},
{
"t": "2026-09-14",
"v": 272.14,
"c": 273.11
},
{
"t": "2026-09-15",
"v": 273.0785,
"c": 272.88
},
{
"t": "2026-09-16",
"v": 275.2034,
"c": 273.41
},
{
"t": "2026-09-17",
"v": 282.4184,
"c": 281.67
},
{
"t": "2026-09-18",
"v": 278.075,
"c": 278.06
},
{
"t": "2026-09-21",
"v": 278.4496,
"c": 279.01
},
{
"t": "2026-09-22",
"v": 285.9627,
"c": 285.11
},
{
"t": "2026-09-23",
"v": 281.7543,
"c": 277.33
},
{
"t": "2026-09-24",
"v": 294.4339,
"c": 294.44
},
{
"t": "2026-09-25",
"v": 292.4418,
"c": 292.84
},
{
"t": "2026-09-28",
"v": 294.654,
"c": 294.59
},
{
"t": "2026-09-29",
"v": 294.1475,
"c": 295.96
},
{
"t": "2026-09-30",
"v": 295.9993,
"c": 294.2075
}
],
"vwap_summary": {
"days": 30,
"days_above": 12,
"days_below": 18,
"pct_days_above": 40,
"position": "below",
"gap_pct": -0.61,
"streak_days": 1
}
}
Data:
{
"volume": 10592,
"avgVolume": 926139,
"short_ratio": [
{
"symbol": "CRL",
"file_date": "2026-09-29",
"date": "20260929",
"short_volume": 155792,
"short_exempt_volume": 0,
"total_volume": 223730,
"short_volume_ratio": 0.6963,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 277.58,
"vah": 295.08,
"val": 275.9,
"profile": [
{
"price": 269.43,
"volume": 68401
},
{
"price": 269.91,
"volume": 209689
},
{
"price": 270.39,
"volume": 68526
},
{
"price": 270.87,
"volume": 100873
},
{
"price": 271.35,
"volume": 102788
},
{
"price": 271.83,
"volume": 181213
},
{
"price": 272.31,
"volume": 316498
},
{
"price": 272.79,
"volume": 421137
},
{
"price": 273.26,
"volume": 340132
},
{
"price": 273.74,
"volume": 333050
},
{
"price": 274.22,
"volume": 220354
},
{
"price": 274.7,
"volume": 52833
},
{
"price": 275.18,
"volume": 64619
},
{
"price": 275.66,
"volume": 41032
},
{
"price": 276.14,
"volume": 86511
},
{
"price": 276.62,
"volume": 224902
},
{
"price": 277.1,
"volume": 321378
},
{
"price": 277.58,
"volume": 679365
},
{
"price": 278.06,
"volume": 636922
},
{
"price": 278.54,
"volume": 411129
},
{
"price": 279.02,
"volume": 101709
},
{
"price": 279.5,
"volume": 223054
},
{
"price": 279.98,
"volume": 67656
},
{
"price": 280.45,
"volume": 108005
},
{
"price": 280.93,
"volume": 158085
},
{
"price": 281.41,
"volume": 221283
},
{
"price": 281.89,
"volume": 147588
},
{
"price": 282.37,
"volume": 143378
},
{
"price": 282.85,
"volume": 166584
},
{
"price": 283.33,
"volume": 166876
},
{
"price": 283.81,
"volume": 159344
},
{
"price": 284.29,
"volume": 198197
},
{
"price": 284.77,
"volume": 85432
},
{
"price": 285.25,
"volume": 351090
},
{
"price": 285.73,
"volume": 69856
},
{
"price": 286.21,
"volume": 97963
},
{
"price": 286.69,
"volume": 184261
},
{
"price": 287.17,
"volume": 269589
},
{
"price": 287.65,
"volume": 254816
},
{
"price": 288.12,
"volume": 207355
},
{
"price": 288.6,
"volume": 317853
},
{
"price": 289.08,
"volume": 364367
},
{
"price": 289.56,
"volume": 244420
},
{
"price": 290.04,
"volume": 249663
},
{
"price": 290.52,
"volume": 129076
},
{
"price": 291.0,
"volume": 156192
},
{
"price": 291.48,
"volume": 179131
},
{
"price": 291.96,
"volume": 296726
},
{
"price": 292.44,
"volume": 294242
},
{
"price": 292.92,
"volume": 435522
},
{
"price": 293.4,
"volume": 250286
},
{
"price": 293.88,
"volume": 153610
},
{
"price": 294.36,
"volume": 57002
},
{
"price": 294.84,
"volume": 543967
},
{
"price": 295.32,
"volume": 132222
},
{
"price": 295.79,
"volume": 231089
},
{
"price": 296.27,
"volume": 170361
},
{
"price": 296.75,
"volume": 124781
},
{
"price": 297.23,
"volume": 123991
},
{
"price": 297.71,
"volume": 142394
}
],
"sessions": 20
}
}
Data:
{
"symbol": "CRL",
"marketCap": 14255712492,
"enterpriseValueTTM": 17091380492,
"evToSalesTTM": 4.273927495138143,
"evToOperatingCashFlowTTM": 29.359167242694298,
"evToFreeCashFlowTTM": 46.117511884621095,
"evToEBITDATTM": 77.52212532260478,
"netDebtToEBITDATTM": 12.861863918610611,
"currentRatioTTM": 1.347531518066598,
"incomeQualityTTM": -2.460879012178677,
"grahamNumberTTM": null,
"grahamNetNetTTM": -78.10880975951821,
"taxBurdenTTM": 1.298288788104818,
"interestBurdenTTM": 2.3726731343090774,
"workingCapitalTTM": 394360000,
"investedCapitalTTM": 5549546000,
"returnOnAssetsTTM": -0.03165871076565839,
"operatingReturnOnAssetsTTM": 0.06470834013379108,
"returnOnTangibleAssetsTTM": -0.056747070526305766,
"returnOnEquityTTM": -0.07723142797479804,
"returnOnInvestedCapitalTTM": 0.07718824478510719,
"returnOnCapitalEmployedTTM": 0.07718824478510719,
"earningsYieldTTM": -0.016617378853943664,
"freeCashFlowYieldTTM": 0.025996946852567038,
"capexToOperatingCashFlowTTM": 0.36338353820677904,
"capexToDepreciationTTM": 0.7101570420502078,
"capexToRevenueTTM": 0.05289914670890403,
"salesGeneralAndAdministrativeToRevenueTTM": 0.18843347077647415,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0.016361393522909676,
"intangiblesToTotalAssetsTTM": 0.44210845648882224,
"averageReceivablesTTM": 706003000,
"averagePayablesTTM": 137467500,
"averageInventoryTTM": 352991500,
"daysOfSalesOutstandingTTM": 64.96409590728852,
"daysOfPayablesOutstandingTTM": 18.990958969932247,
"daysOfInventoryOutstandingTTM": 46.64257004694708,
"operatingCycleTTM": 111.60666595423561,
"cashConversionCycleTTM": 92.61570698430336,
"freeCashFlowToEquityTTM": 692496000,
"freeCashFlowToFirmTTM": 507310375.1544882,
"tangibleAssetValueTTM": -484035000,
"netCurrentAssetValueTTM": -3157049000,
"grossProfitMarginTTM": 0.32241665201712333,
"ebitMarginTTM": -0.019357652325451422,
"ebitdaMarginTTM": 0.055131712106090865,
"operatingProfitMarginTTM": 0.12348227188535496,
"pretaxProfitMarginTTM": -0.04592938161589422,
"continuousOperationsProfitMarginTTM": -0.05909921687667402,
"netProfitMarginTTM": -0.05962960119650301,
"bottomLineProfitMarginTTM": -0.05962960119650301,
"receivablesTurnoverTTM": 5.6184881033501695,
"payablesTurnoverTTM": 19.219671875332487,
"inventoryTurnoverTTM": 7.825469300525617,
"fixedAssetTurnoverTTM": 2.191032462341678,
"assetTurnoverTTM": 0.530922731838009,
"quickRatioTTM": 1.042388340650683,
"solvencyRatioTTM": 0.012680758532314873,
"cashRatioTTM": 0.1692228921714639,
"priceToEarningsRatioTTM": -61.14876033057851,
"priceToEarningsGrowthRatioTTM": 0.6378381374669191,
"forwardPriceToEarningsGrowthRatioTTM": -5.712356400869191,
"priceToEarningsDilutedRatioTTM": -61.02268041237114,
"priceToEarningsDilutedGrowthRatioTTM": 0.6382834309560785,
"priceToBookRatioTTM": 5.053435214935998,
"priceToSalesRatioTTM": 3.5648309164295857,
"priceToFreeCashFlowRatioTTM": 38.466055482251996,
"priceToOperatingCashFlowRatioTTM": 24.649945649559903,
"debtToAssetsRatioTTM": 0.40196955847238736,
"debtToEquityRatioTTM": 1.0662257416091359,
"debtToCapitalRatioTTM": 0.5160257759535898,
"longTermDebtToCapitalRatioTTM": 0.4798840432330376,
"financialLeverageRatioTTM": 2.6525037011786017,
"workingCapitalTurnoverRatioTTM": 10.130917004238329,
"operatingCashFlowRatioTTM": 0.5130205349919718,
"operatingCashFlowSalesRatioTTM": 0.1455738665817118,
"freeCashFlowOperatingCashFlowRatioTTM": 0.636616461793221,
"debtServiceCoverageRatioTTM": 1.579578392621871,
"interestCoverageRatioTTM": 4.647129681912291,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": 0.1922744479047248,
"capitalExpenditureCoverageRatioTTM": 2.7519133225868972,
"dividendPaidAndCapexCoverageRatioTTM": 2.7519133225868972,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 82.47714804273399,
"netIncomePerShareTTM": -4.9180794456131665,
"interestDebtPerShareTTM": 64.63624551416903,
"cashPerShareTTM": 3.9604215649878314,
"bookValuePerShareTTM": 58.6971496926948,
"tangibleBookValuePerShareTTM": -9.982984779111495,
"shareholdersEquityPerShareTTM": 58.56610155508807,
"operatingCashFlowPerShareTTM": 12.006517345213052,
"capexPerShareTTM": 4.362970754444582,
"freeCashFlowPerShareTTM": 7.643546590768469,
"netIncomePerEBTTTM": 1.298288788104818,
"ebtPerEbitTTM": -0.3719512195121951,
"priceToFairValueTTM": 5.053435214935998,
"debtToMarketCapTTM": 0.18378492141099784,
"effectiveTaxRateTTM": -0.28651774096073956,
"enterpriseValueMultipleTTM": 77.52212532260478,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 4015382000
}
],
"dcf": {
"symbol": "CRL",
"date": "2026-09-29",
"dcf": 77.75211558354833,
"Stock Price": 292.035
},
"statements": {
"income": [
{
"date": "2025-12-27",
"symbol": "CRL",
"reportedCurrency": "USD",
"cik": "0001100682",
"filingDate": "2026-02-18",
"acceptedDate": "2026-02-18 09:21:09",
"fiscalYear": "2025",
"period": "FY",
"revenue": 4015382000,
"costOfRevenue": 2789809000,
"grossProfit": 1225573000,
"researchAndDevelopmentExpenses": 0,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 743073000,
"otherExpenses": -25339000,
"operatingExpenses": 717734000,
"costAndExpenses": 3507543000,
"netInterestIncome": -102089000,
"interestIncome": 4940000,
"interestExpense": 107029000,
"depreciationAndAmortization": 403312000,
"ebitda": 410838000,
"ebit": 7526000,
"nonOperatingIncomeExcludingInterest": 500313000,
"operatingIncome": 507839000,
"totalOtherIncomeExpensesNet": -607342000,
"incomeBeforeTax": -99503000,
"incomeTaxExpense": 42660000,
"netIncomeFromContinuingOperations": -142163000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -144338000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -144338000,
"eps": -2.91,
"epsDiluted": -2.91,
"weightedAverageShsOut": 49564000,
"weightedAverageShsOutDil": 49564000
}
],
"balance_sheet": [
{
"date": "2025-12-27",
"symbol": "CRL",
"reportedCurrency": "USD",
"cik": "0001100682",
"filingDate": "2026-02-18",
"acceptedDate": "2026-02-18 09:21:09",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 213770000,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 213770000,
"netReceivables": 708856000,
"accountsReceivables": 708856000,
"otherReceivables": 0,
"inventory": 299103000,
"prepaids": 216008000,
"otherCurrentAssets": 8646000,
"totalCurrentAssets": 1447049000,
"propertyPlantEquipmentNet": 2016634000,
"goodwill": 2764253000,
"intangibleAssets": 339995000,
"goodwillAndIntangibleAssets": 3104248000,
"longTermInvestments": 206972000,
"taxAssets": 67334000,
"otherNonCurrentAssets": 293185000,
"totalNonCurrentAssets": 5688373000,
"otherAssets": 0,
"totalAssets": 7135422000,
"totalPayables": 187800000,
"accountPayables": 148800000,
"otherPayables": 39000000,
"accruedExpenses": 268854000,
"shortTermDebt": 61057000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 210418000,
"otherCurrentLiabilities": 392186000,
"totalCurrentLiabilities": 1120315000,
"longTermDebt": 2545760000,
"capitalLeaseObligationsNonCurrent": 458696000,
"deferredRevenueNonCurrent": 45632000,
"deferredTaxLiabilitiesNonCurrent": 95203000,
"otherNonCurrentLiabilities": -341378000,
"totalNonCurrentLiabilities": 2803913000,
"otherLiabilities": 0,
"capitalLeaseObligations": 458696000,
"totalLiabilities": 3924228000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 492000,
"retainedEarnings": 1388620000,
"additionalPaidInCapital": 1947301000,
"accumulatedOtherComprehensiveIncomeLoss": -171783000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 3164630000,
"totalEquity": 3211194000,
"minorityInterest": 46564000,
"totalLiabilitiesAndTotalEquity": 7135422000,
"totalInvestments": 206972000,
"totalDebt": 3065513000,
"netDebt": 2851743000
}
],
"cash_flow": [
{
"date": "2025-12-27",
"symbol": "CRL",
"reportedCurrency": "USD",
"cik": "0001100682",
"filingDate": "2026-02-18",
"acceptedDate": "2026-02-18 09:21:09",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -142163000,
"depreciationAndAmortization": 403312000,
"deferredIncomeTax": -75292000,
"stockBasedCompensation": 71083000,
"changeInWorkingCapital": 14081000,
"accountsReceivables": 35737000,
"inventory": -48777000,
"accountsPayables": 2869000,
"otherWorkingCapital": 24252000,
"otherNonCashItems": 466625000,
"netCashProvidedByOperatingActivities": 737646000,
"investmentsInPropertyPlantAndEquipment": -219152000,
"acquisitionsNet": 17441000,
"purchasesOfInvestments": -20076000,
"salesMaturitiesOfInvestments": 9102000,
"otherInvestingActivities": 3364000,
"netCashProvidedByInvestingActivities": -209321000,
"netDebtIssuance": -121783000,
"longTermNetDebtIssuance": -121783000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -359959000,
"netCommonStockIssuance": -359959000,
"commonStockIssuance": 714000,
"commonStockRepurchased": -360673000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -54984000,
"netCashProvidedByFinancingActivities": -536726000,
"effectOfForexChangesOnCash": 18828000,
"netChangeInCash": 10427000,
"cashAtEndOfPeriod": 215997000,
"cashAtBeginningOfPeriod": 205570000,
"operatingCashFlow": 737646000,
"capitalExpenditure": -219152000,
"freeCashFlow": 518494000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 293.655,
"rsi": 59.55111452000571,
"sma20": 283.5897499999998,
"sma50": 273.3741000000002,
"sma200": 209.01297500000013,
"adx": 27.774114304645355,
"atr": 10.09,
"atr_pct": 3.44,
"atr_expansion_pct": 19.1,
"di_plus": 23.8,
"di_minus": 6.0,
"high_52w": 298.58,
"low_52w": 145.57,
"structure": {
"ema8": 289.3441153212657,
"ema21": 284.6241764760918,
"ema50": 270.208167005243,
"ema200": 220.19809450088843,
"ema10": 288.2844878102339,
"ema20": 284.9567164848876,
"ema10_slope_pct": 3.13,
"ema20_slope_pct": 1.96,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 3.2,
"_no_bars": false,
"macd": {
"macd": 4.733,
"signal": 4.079,
"histogram": 0.654
},
"bollinger": {
"mid": 283.59,
"upper": 299.58,
"lower": 267.6,
"width_pct": 11.28
},
"crossover": {
"fresh_cross": true,
"pre_compressed": true,
"held_above_21": false,
"candles_since": 6,
"intraday_support": false
},
"momentum": {
"roc10": 7.4,
"ret_3d": 0.28,
"ret_5d": 5.89,
"roc10_accel": 7.77,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.01,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 0.86,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 269173038.96
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.9,
"iv_rank": 41.0
}
}
}
}
Data:
{
"prior_day": {
"high": 296.97,
"low": 293.45,
"close": 294.21,
"date": "2026-09-30"
},
"woodie_pivots": {
"PP": 294.71,
"R1": 295.96,
"S1": 292.45,
"R2": 298.23,
"S2": 291.19
},
"swing": {
"high_20d": 298.4,
"low_20d": 267.27,
"high_60d": 303.31,
"low_60d": 213.4
},
"orb": {
"high": 296.97,
"low": 293.45,
"date": "2026-09-30"
},
"vwap": 295.76,
"volume_profile": {
"poc": 277.58,
"vah": 295.08,
"val": 275.9,
"sessions": 20
},
"intraday": {
"h1_trend": "up",
"h1_last": 294.21,
"h1_ema9": 293.05,
"h1_ema21": 292.46,
"m15_trend": "up",
"m15_last": 294.21,
"m15_ema9": 294.02,
"m15_ema21": 293.28,
"rvol_intraday": 0.5,
"as_of_et": "2026-09-30 09:30"
},
"premarket": {
"date": "2026-09-30",
"high": 299,
"low": 296.26,
"last": 296.26,
"volume": 851,
"gap_pct": 0.1,
"path": "08:30 299.00 -> 09:05 298.01 -> 09:25 296.26",
"bars": 3,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-08-26",
"o": 293.17,
"h": 299.53,
"l": 290.01,
"c": 295.1,
"v": 1231129.937448
},
{
"d": "2026-08-27",
"o": 297.01,
"h": 303.305,
"l": 295.93,
"c": 296.41,
"v": 901386.724947
},
{
"d": "2026-08-28",
"o": 291.66,
"h": 294.885,
"l": 289.5979,
"c": 291.5,
"v": 659870.303711
},
{
"d": "2026-08-31",
"o": 285.91,
"h": 291.405,
"l": 284.34,
"c": 288.24,
"v": 1086241.25686
},
{
"d": "2026-09-01",
"o": 289.26,
"h": 290.5299,
"l": 280.91,
"c": 282.34,
"v": 705710.143682
},
{
"d": "2026-09-02",
"o": 285.49,
"h": 292.545,
"l": 282.56,
"c": 291.76,
"v": 606455.588114
},
{
"d": "2026-09-03",
"o": 294.21,
"h": 295.77,
"l": 285.56,
"c": 293.35,
"v": 646350.106942
},
{
"d": "2026-09-04",
"o": 288.29,
"h": 291.69,
"l": 285.34,
"c": 288.5,
"v": 738889.014382
},
{
"d": "2026-09-08",
"o": 285.6,
"h": 285.94,
"l": 280.1584,
"c": 280.76,
"v": 729160.443431
},
{
"d": "2026-09-09",
"o": 278.54,
"h": 280.745,
"l": 275,
"c": 278.35,
"v": 789217.841356
},
{
"d": "2026-09-10",
"o": 275.38,
"h": 275.88,
"l": 272.0599,
"c": 273,
"v": 764684.207863
},
{
"d": "2026-09-11",
"o": 276.01,
"h": 280.4,
"l": 275.63,
"c": 278.26,
"v": 767560.583917
},
{
"d": "2026-09-14",
"o": 278.27,
"h": 279.64,
"l": 267.27,
"c": 273.11,
"v": 1385131.868546
},
{
"d": "2026-09-15",
"o": 272.27,
"h": 276.09,
"l": 269.93,
"c": 272.88,
"v": 983750.876404
},
{
"d": "2026-09-16",
"o": 272.78,
"h": 282.905,
"l": 270.88,
"c": 273.41,
"v": 1014795.15299
},
{
"d": "2026-09-17",
"o": 280.11,
"h": 285.5775,
"l": 274.4,
"c": 281.67,
"v": 809837.38578
},
{
"d": "2026-09-18",
"o": 281.26,
"h": 282.995,
"l": 276,
"c": 278.06,
"v": 1481168.83887
},
{
"d": "2026-09-21",
"o": 279.37,
"h": 281.63,
"l": 275.88,
"c": 279.01,
"v": 952932.761722
},
{
"d": "2026-09-22",
"o": 280.19,
"h": 290.11,
"l": 277.41,
"c": 285.11,
"v": 1137111.389407
},
{
"d": "2026-09-23",
"o": 283.85,
"h": 291.09,
"l": 276.64,
"c": 277.33,
"v": 1594221.689745
},
{
"d": "2026-09-24",
"o": 277,
"h": 298.4,
"l": 276.95,
"c": 294.44,
"v": 1590892.009934
},
{
"d": "2026-09-25",
"o": 293.19,
"h": 295.2276,
"l": 287.2348,
"c": 292.84,
"v": 838263.549131
},
{
"d": "2026-09-28",
"o": 289.13,
"h": 296.8825,
"l": 289.13,
"c": 294.59,
"v": 901741.965493
},
{
"d": "2026-09-29",
"o": 294.71,
"h": 298.2,
"l": 289.38,
"c": 295.96,
"v": 661450.072138
},
{
"d": "2026-09-30",
"o": 296.97,
"h": 296.97,
"l": 293.455,
"c": 294.2075,
"v": 10222.620775
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 0.49,
"etf_rvol": 1.17,
"rs_5d": 3.31,
"leading": true
}
Data:
{
"estimates": [
{
"symbol": "CRL",
"date": "2030-12-27",
"revenueLow": 4723239469,
"revenueHigh": 4861941093,
"revenueAvg": 4787326000,
"ebitdaLow": 1605806698,
"ebitdaHigh": 1649986056,
"ebitdaAvg": 1626219802,
"ebitLow": 1275897942,
"ebitHigh": 1320077300,
"ebitAvg": 1296311046,
"netIncomeLow": 811609525,
"netIncomeHigh": 842719857,
"netIncomeAvg": 825984076,
"sgaExpenseLow": 844496945,
"sgaExpenseHigh": 869296259,
"sgaExpenseAvg": 855955369,
"epsAvg": 16.665,
"epsHigh": 17.00266,
"epsLow": 16.37498,
"numAnalystsRevenue": 6,
"numAnalystsEps": 1
},
{
"symbol": "CRL",
"date": "2029-12-27",
"revenueLow": 4458035519,
"revenueHigh": 4588949222,
"revenueAvg": 4518523672,
"ebitdaLow": 1570571922,
"ebitdaHigh": 1613318238,
"ebitdaAvg": 1590322702,
"ebitLow": 1238500898,
"ebitHigh": 1281247214,
"ebitAvg": 1258251678,
"netIncomeLow": 785275180,
"netIncomeHigh": 815376389,
"netIncomeAvg": 799183334,
"sgaExpenseLow": 797079505,
"sgaExpenseHigh": 820486369,
"sgaExpenseAvg": 807894553,
"epsAvg": 16.12427,
"epsHigh": 16.45098,
"epsLow": 15.84366,
"numAnalystsRevenue": 6,
"numAnalystsEps": 1
},
{
"symbol": "CRL",
"date": "2028-12-27",
"revenueLow": 4067305180,
"revenueHigh": 4344563787,
"revenueAvg": 4200647404,
"ebitdaLow": 1080445603,
"ebitdaHigh": 1713547460,
"ebitdaAvg": 1437984335,
"ebitLow": 741162163,
"ebitHigh": 1374264020,
"ebitAvg": 1098700895,
"netIncomeLow": 435057931,
"netIncomeHigh": 880877199,
"netIncomeAvg": 686830460,
"sgaExpenseLow": 727218432,
"sgaExpenseHigh": 776791198,
"sgaExpenseAvg": 751059506,
"epsAvg": 14.17417,
"epsHigh": 17.77252,
"epsLow": 8.7777,
"numAnalystsRevenue": 10,
"numAnalystsEps": 5
},
{
"symbol": "CRL",
"date": "2027-12-27",
"revenueLow": 3931008977,
"revenueHigh": 4071044920,
"revenueAvg": 3991024382,
"ebitdaLow": 1320719104,
"ebitdaHigh": 1398712198,
"ebitdaAvg": 1352137685,
"ebitLow": 967087269,
"ebitHigh": 1045080363,
"ebitAvg": 998505850,
"netIncomeLow": 594150444,
"netIncomeHigh": 649071818,
"netIncomeAvg": 616274860,
"sgaExpenseLow": 702849198,
"sgaExpenseHigh": 727887083,
"sgaExpenseAvg": 713579720,
"epsAvg": 12.74306,
"epsHigh": 13.09563,
"epsLow": 11.98754,
"numAnalystsRevenue": 11,
"numAnalystsEps": 10
}
],
"price_target": {
"symbol": "CRL",
"targetHigh": 357,
"targetLow": 219,
"targetConsensus": 305.5,
"targetMedian": 321
},
"ratings": {
"symbol": "CRL",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "CRL",
"date": "2026-09-28",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "Baird",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "Deutsche Bank",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-25",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-09-11",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-08-10",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-08-07",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-08-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-08-06",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-08-06",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Overweight",
"action": "upgrade"
},
{
"symbol": "CRL",
"date": "2026-07-20",
"gradingCompany": "CLSA",
"previousGrade": "Outperform",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "CRL",
"date": "2026-07-13",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-07-09",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-06-17",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Overweight",
"action": "upgrade"
},
{
"symbol": "CRL",
"date": "2026-05-29",
"gradingCompany": "CLSA",
"previousGrade": "Hold",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "CRL",
"date": "2026-05-08",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-05-08",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-04-14",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-04-13",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-02-25",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-02-20",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-02-20",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-02-19",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-02-19",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-01-16",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2026-01-13",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-12-18",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-12-15",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-12-15",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-11-11",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-11-10",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-11-06",
"gradingCompany": "Baird",
"previousGrade": "Neutral",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "CRL",
"date": "2025-11-06",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-11-06",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-10-17",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-10-06",
"gradingCompany": "William Blair",
"previousGrade": "Market Perform",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "CRL",
"date": "2025-10-03",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CRL",
"date": "2025-10-02",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Overweight",
"action": "upgrade"
}
]
}
Data:
[
{
"title": "UBS Reinstates Buy on Charles River, Announces $357 Price Target",
"url": "https://www.benzinga.com/news/26/09/62076835/ubs-reinstates-buy-charles-river-announces-357-price-target",
"source": "benzinga",
"date": "2026-09-30T12:42:19.419000+00:00",
"summary": "UBS analyst Kevin Caliendo reinstates Charles River (NYSE:CRL) with a Buy and announces $357 price target.",
"image": ""
},
{
"title": "Charles River Laboratories International, Inc. (NYSE:CRL) Stock Has Consensus Price Target of $290.00 According to Analysts",
"url": "https://www.defenseworld.net/2026/09/30/charles-river-laboratories-international-inc-nysecrl-stock-has-consensus-price-target-of-290-00-according-to-analysts.html",
"source": "Defense World",
"date": "2026-09-30 02:29:00",
"summary": "Shares of Charles River Laboratories International, Inc. (NYSE: CRL - Get Free Report) have been assigned an average recommendation of \"Moderate Buy\" from the seventeen ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the s",
"image": "https://images.financialmodelingprep.com/news/charles-river-laboratories-international-inc-nysecrl-stock-has-consensus-20260930.png"
},
{
"title": "Pharmaceutical Impurity Synthesis and Isolation Services Report: Capitalize on a $2.1 Billion Market by 2030 as Tariffs and 8.9% Isolation Growth Reshape Competition Across Eurofins, WuXi AppTec, Cambrex and Charles River",
"url": "https://www.globenewswire.com/news-release/2026/09/29/3371158/28124/en/pharmaceutical-impurity-synthesis-and-isolation-services-report-capitalize-on-a-2-1-billion-market-by-2030-as-tariffs-and-8-9-isolation-growth-reshape-competition-across-eurofins-w.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-29T15:52:00Z",
"summary": "The global pharmaceutical impurity synthesis and isolation services market is projected to grow from $1.3 billion in 2024 to $2.1 billion by 2030 at a 7.7% CAGR. Growth is driven by stricter regulatory requirements, increasing drug complexity, biologics expansion, and rising phar",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan",
"url": "https://www.marketbeat.com/instant-alerts/event-charles-river-targets-5-7-growth-300m-savings-in-2030-plan-2026-09-25/",
"source": "MarketBeat",
"date": "2026-09-25 21:02:21",
"summary": "Charles River Laboratories International NYSE: CRL outlined a strategy to accelerate growth, expand margins and modernize its operations during its 2026 Investor Day, setting financial targets through 2030 that include 5% to 7% organic revenue growth, an approximately 24% non-GAA",
"image": "https://images.financialmodelingprep.com/news/charles-river-targets-57-growth-300m-savings-in-2030-20260925.jpg"
},
{
"title": "Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day Transcript",
"url": "https://seekingalpha.com/article/4949537-charles-river-laboratories-international-inc-crl-analyst-investor-day-transcript",
"source": "Seeking Alpha",
"date": "2026-09-24 15:29:59",
"summary": "Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day Transcript",
"image": "https://images.financialmodelingprep.com/news/charles-river-laboratories-international-inc-crl-analystinvestor-day-transcript-20260924.jpg"
},
{
"title": "Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day",
"url": "https://www.businesswire.com/news/home/20260924597077/en/Charles-River-Highlights-Refreshed-Strategic-Vision-to-Drive-Profitable-Growth-and-Long-Term-Value-Creation-at-2026-Investor-Day/",
"source": "Business Wire",
"date": "2026-09-24 08:00:00",
"summary": "WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day.",
"image": "https://images.financialmodelingprep.com/news/charles-river-highlights-refreshed-strategic-vision-to-drive-profitable-20260924.jpg"
},
{
"title": "Financial Comparison: Charles River Laboratories International (NYSE:CRL) versus Adaptive Biotechnologies (NASDAQ:ADPT)",
"url": "https://www.defenseworld.net/2026/09/24/financial-comparison-charles-river-laboratories-international-nysecrl-versus-adaptive-biotechnologies-nasdaqadpt.html",
"source": "Defense World",
"date": "2026-09-24 04:15:20",
"summary": "Adaptive Biotechnologies (NASDAQ: ADPT - Get Free Report) and Charles River Laboratories International (NYSE: CRL - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, ris",
"image": "https://images.financialmodelingprep.com/news/financial-comparison-charles-river-laboratories-international-nysecrl-versus-adaptive-20260924.png"
},
{
"title": "Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook",
"url": "https://www.globenewswire.com/news-release/2026/09/21/3365223/28124/en/rare-disease-contract-research-organization-cro-market-outlook-2026-2030-investment-trends-strategic-profiles-and-revenue-share-outlook.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-21T08:55:00Z",
"summary": "The global rare disease CRO market is projected to grow from $2.07 billion in 2025 to $3.16 billion by 2030, with an 8.9% CAGR. Growth is driven by expanding gene and cell therapy pipelines, increasing orphan drug approvals, precision medicine adoption, and decentralized clinical",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "PGNY vs. CRL: Which Stock Is the Better Value Option?",
"url": "https://www.zacks.com/stock/news/2992182/pgny-vs-crl-which-stock-is-the-better-value-option?cid=CS-ZC-FT-fundamental_analysis|yseop_template_3-2992182",
"source": "Zacks Investment Research",
"date": "2026-09-18T15:40:04Z",
"summary": "A comparison of two Medical Services sector stocks, Progyny (PGNY) and Charles River Laboratories (CRL), both with Zacks Rank #2 (Buy). Based on valuation metrics including forward P/E ratio (12.92 vs 24.87), PEG ratio (1.12 vs 2.76), and Value grades (B vs D), Progyny is identif",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default237.jpg"
},
{
"title": "Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines",
"url": "https://www.businesswire.com/news/home/20260916131517/en/Charles-River-Leverages-Expertise-in-Rapid-and-In-Vitro-Methods-to-Reduce-Cell-Banking-Timelines/",
"source": "Business Wire",
"date": "2026-09-17 08:00:00",
"summary": "WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) has introduced rapid cell banking programs designed to significantly accelerate release timelines, enabling biopharmaceutical and advanced therapy developers to reach cri",
"image": "https://images.financialmodelingprep.com/news/charles-river-leverages-expertise-in-rapid-and-in-vitro-20260917.jpg"
},
{
"title": "Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946537-charles-river-laboratories-international-inc-crl-presents-at-2026-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-15 12:31:37",
"summary": "Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/charles-river-laboratories-international-inc-crl-presents-at-2026-20260915.jpg"
},
{
"title": "Beat the Market the Zacks Way: FIGS, Microsoft, Amphenol in Focus",
"url": "https://www.zacks.com/stock/news/2988917/beat-the-market-the-zacks-way-figs-microsoft-amphenol-in-focus?cid=CS-ZC-FT-analyst_blog|investment_ideas-2988917",
"source": "Zacks Investment Research",
"date": "2026-09-14T12:11:00Z",
"summary": "Zacks Investment Research showcases the performance of its various stock rating systems and portfolios. The Zacks Rank #1 portfolio outperformed the S&P 500 by 2.3 percentage points year-to-date, while individual stocks like FIGS and CRL surged following rank upgrades. The Focus ",
"image": "https://staticx-tuner.zacks.com/images/articles/main/e6/86.jpg"
},
{
"title": "Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946076-charles-river-laboratories-international-inc-crl-presents-at-morgan-stanley-24th-annual",
"source": "Seeking Alpha",
"date": "2026-09-14 12:31:39",
"summary": "Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/charles-river-laboratories-international-inc-crl-presents-at-morgan-20260914.jpg"
},
{
"title": "Charles River Laboratories to Present at Morgan Stanley and Baird Conferences",
"url": "https://www.gurufocus.com/news/9077649/charles-river-laboratories-to-present-at-morgan-stanley-and-baird-conferences",
"source": "GuruFocus",
"date": "2026-09-11 09:00:00",
"summary": "Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:Morgan Stanley 2",
"image": "https://images.financialmodelingprep.com/news/charles-river-laboratories-to-present-at-morgan-stanley-and-20260911.png"
},
{
"title": "Amundi Sells 360,913 Shares of Charles River Laboratories International, Inc. $CRL",
"url": "https://www.defenseworld.net/2026/09/10/amundi-sells-360913-shares-of-charles-river-laboratories-international-inc-crl.html",
"source": "Defense World",
"date": "2026-09-10 03:07:41",
"summary": "Amundi trimmed its position in Charles River Laboratories International, Inc. (NYSE: CRL) by 46.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 412,402 shares of the medical r",
"image": "https://images.financialmodelingprep.com/news/amundi-sells-360913-shares-of-charles-river-laboratories-international-20260910.png"
},
{
"title": "Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?",
"url": "https://www.fool.com/coverage/etfs/2026/09/08/does-ishares-pharma-etf-offer-superior-returns-to-invesco-s-equal-weight-healthcare-fund/",
"source": "Fool - Investing News",
"date": "2026-09-08 14:59:01",
"summary": "IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharply too.",
"image": "https://images.financialmodelingprep.com/news/does-ishares-pharma-etf-offer-superior-returns-to-invescos-20260908.jpg"
},
{
"title": "Charles River Modernizes Endosafe\u00ae Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite",
"url": "https://www.businesswire.com/news/home/20260908778943/en/Charles-River-Modernizes-Endosafe%C2%AE-Endotoxin-Testing-Cartridge-Manufacturing-with-Fully-Automated-Production-Suite/",
"source": "Business Wire",
"date": "2026-09-08 08:00:00",
"summary": "WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) has successfully implemented its Endosafe\u00ae Cartridge Technology Automated Manufacturing Suite, a significant advancement in bacterial endotoxin testing cartridge producti",
"image": "https://images.financialmodelingprep.com/news/charles-river-modernizes-endosafe-endotoxin-testing-cartridge-manufacturing-with-20260908.jpg"
},
{
"title": "Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?",
"url": "https://www.zacks.com/stock/news/2985234/charles-river-crl-up-10-5-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2985234",
"source": "Zacks Investment Research",
"date": "2026-09-04T15:30:28Z",
"summary": "Charles River Laboratories (CRL) shares have gained 10.5% since its Q2 2026 earnings report, outperforming the S&P 500. The company beat earnings estimates with non-GAAP EPS of $3.02 and raised its 2026 guidance, though revenues declined 2.7% year-over-year. However, estimates ha",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg"
},
{
"title": "Global Pathology Services Market to Reach $307.9 Billion by 2030, Driven by Rising Cancer Incidence and AI-Enabled Diagnostic Innovation",
"url": "https://www.globenewswire.com/news-release/2026/08/31/3353486/0/en/global-pathology-services-market-to-reach-307-9-billion-by-2030-driven-by-rising-cancer-incidence-and-ai-enabled-diagnostic-innovation.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-31T14:53:00Z",
"summary": "The global pathology services market is projected to grow from $212.8 billion in 2024 to $307.9 billion by 2030 at a 6.5% CAGR, driven by rising cancer incidence, digital pathology adoption, and molecular diagnostics expansion. North America leads with 41.2% market share, while A",
"image": "https://ml.globenewswire.com/Resource/Download/d0c282b6-d496-45a8-a941-33fa5c3e824c"
},
{
"title": "Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?",
"url": "https://www.zacks.com/stock/news/2982276/is-invesco-s-p-500-equal-weight-health-care-etf-rsph-a-strong-etf-right-now?cid=CS-ZC-FT-smart_beta_etf-2982276",
"source": "Zacks Investment Research",
"date": "2026-08-31T10:20:03Z",
"summary": "RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternat",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default74.jpg"
},
{
"title": "Animal Testing and Non-Animal Alternative Testing Market Outlook 2025-2035 - Featuring Profiles of Charles River Laboratories, Labcorp, and Eurofins Scientific",
"url": "https://www.globenewswire.com/news-release/2026/08/27/3351868/28124/en/animal-testing-and-non-animal-alternative-testing-market-outlook-2025-2035-featuring-profiles-of-charles-river-laboratories-labcorp-and-eurofins-scientific.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-27T10:52:00Z",
"summary": "The global animal testing and non-animal alternative testing market reached $15.19 billion in 2025 and is projected to grow to $23.01 billion by 2035 at a CAGR of 4-4.5%. While animal testing dominated with 80.1% market share in 2025, non-animal alternative testing is expected to",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Large Molecule Bioanalytical Testing Services Global Market Report 2026-2035 | Identify High-Growth Opportunities and Develop Informed Commercial Strategies",
"url": "https://www.globenewswire.com/news-release/2026/08/26/3351254/28124/en/large-molecule-bioanalytical-testing-services-global-market-report-2026-2035-identify-high-growth-opportunities-and-develop-informed-commercial-strategies.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-26T11:58:00Z",
"summary": "The global large molecule bioanalytical testing services market is projected to grow from USD 3.11 billion in 2026 to USD 5.88 billion by 2035, with a CAGR of 7.3%. Growth is driven by increasing biologics pipelines, demand for personalized therapies, and outsourcing to CROs and ",
"image": "https://ml.globenewswire.com/Resource/Download/a843f4aa-415d-45ff-ab0c-22656653426d"
},
{
"title": "State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption",
"url": "https://www.globenewswire.com/news-release/2026/08/25/3350469/0/en/state-of-the-life-sciences-industry-to-be-reviewed-in-bcc-research-s-2026-second-quarter-outlook-spotlighting-ai-driven-discovery-precision-oncology-and-connected-health-adoption.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-25T12:54:00Z",
"summary": "BCC Research's mid-year assessment highlights AI-driven discovery, precision oncology, and connected health as major growth themes in the life sciences sector. Key opportunities include smart inhalers with AI integration, genomic profiling platforms, cardiovascular drug innovatio",
"image": "https://ml.globenewswire.com/Resource/Download/d0c282b6-d496-45a8-a941-33fa5c3e824c"
},
{
"title": "Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth",
"url": "https://www.globenewswire.com/news-release/2026/07/15/3327567/28124/en/Global-Clinical-Trials-Market-to-Reach-176-32-Billion-by-2030-as-AI-and-Decentralized-Research-Accelerate-Growth.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-15T10:46:00Z",
"summary": "The global clinical trials market is projected to grow from $127.16 billion in 2025 to $176.32 billion by 2030, with a CAGR of 6.8%. Growth is driven by AI-enabled trial design, decentralized and virtual trials, precision medicine, and real-world evidence studies. North America l",
"image": "https://ml.globenewswire.com/Resource/Download/f7174e11-117f-439a-9315-d19e228bf35f"
},
{
"title": "Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/06/18/3314441/0/en/Global-Cell-and-Gene-Therapy-CDMO-Market-Anticipating-Remarkable-Growth-at-a-CAGR-of-24-by-2034-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-18T17:00:00Z",
"summary": "The cell and gene therapy CDMO market is projected to grow from USD 8.3 billion in 2025 to USD 57.1 billion by 2034, driven by increasing clinical development of advanced therapies, rising outsourcing trends among biopharma companies, and technological advancements in manufacturi",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
}
]
Data:
[
{
"symbol": "CRL",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": 2.96,
"revenueActual": null,
"revenueEstimated": 959751900,
"lastUpdated": "2026-09-30"
},
{
"symbol": "CRL",
"date": "2026-08-05",
"epsActual": 3.02,
"epsEstimated": 2.74,
"revenueActual": 1004078000,
"revenueEstimated": 977198100,
"lastUpdated": "2026-09-30"
},
{
"symbol": "CRL",
"date": "2026-05-07",
"epsActual": 2.06,
"epsEstimated": 1.96,
"revenueActual": 995830000,
"revenueEstimated": 977455600,
"lastUpdated": "2026-08-07"
},
{
"symbol": "CRL",
"date": "2026-02-18",
"epsActual": 2.39,
"epsEstimated": 2.33,
"revenueActual": 994227000,
"revenueEstimated": 987024500,
"lastUpdated": "2026-05-18"
},
{
"symbol": "CRL",
"date": "2025-11-05",
"epsActual": 2.43,
"epsEstimated": 2.32,
"revenueActual": 1004852000,
"revenueEstimated": 987199700,
"lastUpdated": "2026-02-03"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "CRL",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "CRL",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 81156,
"price": 225.57
},
{
"file_period": "202607a",
"settlement_date": "20260706",
"quantity_fails": 23277,
"price": 230.69
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 1549,
"price": 234.62
},
{
"file_period": "202608a",
"settlement_date": "20260814",
"quantity_fails": 1510,
"price": 281.27
},
{
"file_period": "202608b",
"settlement_date": "20260831",
"quantity_fails": 55,
"price": 291.5
},
{
"file_period": "202609a",
"settlement_date": "20260909",
"quantity_fails": 227,
"price": 280.76
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "CRL",
"filingDate": "2026-08-27",
"transactionDate": "2026-08-25",
"reportingCik": "0001141722",
"companyCik": "0001100682",
"transactionType": "M-Exempt",
"securitiesOwned": 65157,
"reportingName": "FOSTER JAMES C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 12429,
"price": 208.44,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/0001100682-26-000140-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-27",
"transactionDate": "2026-08-25",
"reportingCik": "0001141722",
"companyCik": "0001100682",
"transactionType": "M-Exempt",
"securitiesOwned": 52728,
"reportingName": "FOSTER JAMES C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 21132,
"price": 194.12,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/0001100682-26-000140-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-27",
"transactionDate": "2026-08-25",
"reportingCik": "0001141722",
"companyCik": "0001100682",
"transactionType": "S-Sale",
"securitiesOwned": 31596,
"reportingName": "FOSTER JAMES C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 33561,
"price": 300,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/0001100682-26-000140-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-27",
"transactionDate": "2026-08-25",
"reportingCik": "0001141722",
"companyCik": "0001100682",
"transactionType": "M-Exempt",
"securitiesOwned": 12429,
"reportingName": "FOSTER JAMES C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 12429,
"price": 208.44,
"securityName": "Stock Options (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/0001100682-26-000140-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-27",
"transactionDate": "2026-08-25",
"reportingCik": "0001141722",
"companyCik": "0001100682",
"transactionType": "M-Exempt",
"securitiesOwned": 7044,
"reportingName": "FOSTER JAMES C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 21132,
"price": 194.12,
"securityName": "Stock Options (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/0001100682-26-000140-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-19",
"reportingCik": "0001732091",
"companyCik": "0001100682",
"transactionType": "G-Gift",
"securitiesOwned": 35485,
"reportingName": "Girshick Birgit",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 528,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000138/0001100682-26-000138-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-19",
"reportingCik": "0001952784",
"companyCik": "0001100682",
"transactionType": "M-Exempt",
"securitiesOwned": 6846,
"reportingName": "Parisotto Shannon M",
"typeOfOwner": "officer: CEVP, Disc & Safety Assessment",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2039,
"price": 194.12,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000136/0001100682-26-000136-index.htm"
},
{
"symbol": "CRL",
"filingDate": "2026-08-20",
"transactionDate": "2026-08-19",
"reportingCik": "0001952784",
"companyCik": "0001100682",
"transactionType": "S-Sale",
"securitiesOwned": 4807,
"reportingName": "Parisotto Shannon M",
"typeOfOwner": "officer: CEVP, Disc & Safety Assessment",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2039,
"price": 294.12,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1100682/000110068226000136/0001100682-26-000136-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "CRL",
"senateID": "S001229",
"disclosureDate": "2025-06-23",
"transactionDate": "2025-05-12",
"firstName": "Jefferson",
"lastName": "Shreve",
"office": "Jefferson Shreve",
"district": "IN06",
"owner": "",
"assetDescription": "Charles River Laboratories International, Inc. Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030387.pdf"
},
{
"symbol": "CRL",
"senateID": "S001229",
"disclosureDate": "2025-06-23",
"transactionDate": "2025-05-08",
"firstName": "Jefferson",
"lastName": "Shreve",
"office": "Jefferson Shreve",
"district": "IN06",
"owner": "",
"assetDescription": "Charles River Laboratories International, Inc. Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030387.pdf"
},
{
"symbol": "CRL",
"senateID": "B001327",
"disclosureDate": "2025-06-02",
"transactionDate": "2025-05-15",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Charles River Laboratories International, Inc. Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030433.pdf"
},
{
"symbol": "CRL",
"senateID": "B001327",
"disclosureDate": "2025-05-08",
"transactionDate": "2025-04-08",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Charles River Laboratories International, Inc. Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030291.pdf"
},
{
"symbol": "CRL",
"senateID": "J000310",
"disclosureDate": "2025-02-12",
"transactionDate": "2025-01-15",
"firstName": "Julie",
"lastName": "Johnson",
"office": "Julie Johnson",
"district": "TX32",
"owner": "Joint",
"assetDescription": "Charles River Laboratories International, Inc. Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20026762.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2024-12-06",
"transactionDate": "2024-11-15",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220691.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2023-12-06",
"transactionDate": "2023-11-03",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220067.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2023-11-08",
"transactionDate": "2023-10-02",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220039.pdf"
},
{
"symbol": "CRL",
"senateID": "F000462",
"disclosureDate": "2023-10-10",
"transactionDate": "2023-09-08",
"firstName": "Lois",
"lastName": "Frankel",
"office": "Lois Frankel",
"district": "FL22",
"owner": "",
"assetDescription": "Charles River Laboratories International, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023816.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2023-09-06",
"transactionDate": "2023-08-29",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219953.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2023-06-12",
"transactionDate": "2023-05-23",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219783.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2023-06-12",
"transactionDate": "2023-05-19",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219783.pdf"
},
{
"symbol": "CRL",
"senateID": "F000462",
"disclosureDate": "2023-05-19",
"transactionDate": "2023-04-25",
"firstName": "Lois",
"lastName": "Frankel",
"office": "Lois Frankel",
"district": "FL22",
"owner": "",
"assetDescription": "Charles River Laboratories International, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022974.pdf"
},
{
"symbol": "CRL",
"senateID": "L000397",
"disclosureDate": "2022-09-13",
"transactionDate": "2022-08-25",
"firstName": "Zoe",
"lastName": "Lofgren",
"office": "Zoe Lofgren",
"district": "CA19",
"owner": "Spouse",
"assetDescription": "Charles River Laboratories International, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021699.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2022-07-07",
"transactionDate": "2022-06-16",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219068.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2022-06-10",
"transactionDate": "2022-05-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218940.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2022-06-10",
"transactionDate": "2022-05-23",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218940.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2022-06-10",
"transactionDate": "2022-05-05",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218940.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2022-03-08",
"transactionDate": "2022-02-17",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218597.pdf"
},
{
"symbol": "CRL",
"senateID": "K000389",
"disclosureDate": "2022-02-08",
"transactionDate": "2022-01-20",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Charles River Laboratories International Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218560.pdf"
}
],
"dark_pool": [
{
"ticker": "CRL",
"executed_at": "2026-09-29T20:00:20.765000Z",
"size": 2700.0,
"price": 295.96,
"premium": 799092.0,
"volume": 2700.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T20:00:12.639000Z",
"size": 2600.0,
"price": 295.96,
"premium": 769496.0,
"volume": 2600.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T20:00:12.661000Z",
"size": 2400.0,
"price": 295.96,
"premium": 710304.0,
"volume": 2400.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T20:02:17.092000Z",
"size": 1629.0,
"price": 295.96,
"premium": 482118.83999999997,
"volume": 1629.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T21:10:18.254000Z",
"size": 1626.0,
"price": 295.96,
"premium": 481230.95999999996,
"volume": 1626.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T20:00:02.762000Z",
"size": 758.0,
"price": 295.96,
"premium": 224337.68,
"volume": 758.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T19:59:54.248000Z",
"size": 700.0,
"price": 296.31,
"premium": 207417.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "CRL",
"executed_at": "2026-09-29T20:00:12.665000Z",
"size": 600.0,
"price": 295.96,
"premium": 177576.0,
"volume": 600.0,
"trade_code": " "
}
],
"ats": {
"symbol": "CRL",
"date": "20260929",
"ats_volume": 0,
"total_volume": 223730,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260929",
"ats_ratio": 0.0
},
{
"date": "20260928",
"ats_ratio": 0.0
},
{
"date": "20260925",
"ats_ratio": 0.0
},
{
"date": "20260924",
"ats_ratio": 0.0
},
{
"date": "20260923",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "CRL",
"days": [
{
"date": "2026-09-30",
"close": 294.2075,
"vwap": 296.0,
"volume": 10222,
"vwap_discount_pct": 0.61
},
{
"date": "2026-09-29",
"close": 295.96,
"vwap": 294.15,
"volume": 661450,
"vwap_discount_pct": -0.61
},
{
"date": "2026-09-28",
"close": 294.59,
"vwap": 294.65,
"volume": 901741,
"vwap_discount_pct": 0.02
},
{
"date": "2026-09-25",
"close": 292.84,
"vwap": 292.44,
"volume": 838263,
"vwap_discount_pct": -0.14
},
{
"date": "2026-09-24",
"close": 294.44,
"vwap": 294.43,
"volume": 1590892,
"vwap_discount_pct": -0.0
}
],
"avg_vwap_discount_pct": -0.02,
"signal": "Neutral"
},
"options_flow": [
{
"underlying_symbol": "CRL",
"premium": "22400.00",
"price": "11.20",
"open_interest": 503,
"nbbo_ask": "11.20",
"size": 20,
"delta": "0.52839778159349",
"volume": 40,
"option_type": "call",
"nbbo_bid": "10.20",
"option_chain_id": "CRL261016C00290000",
"executed_at": "2026-09-29T14:59:09.147000Z",
"strike": "290",
"underlying_price": "290.115",
"expiry": "2026-10-16",
"implied_volatility": "0.4357075050442936",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "21600.00",
"price": "10.80",
"open_interest": 503,
"nbbo_ask": "11.90",
"size": 20,
"delta": "0.527488756979546",
"volume": 100,
"option_type": "call",
"nbbo_bid": "10.20",
"option_chain_id": "CRL261016C00290000",
"executed_at": "2026-09-29T15:07:22.839000Z",
"strike": "290",
"underlying_price": "290.075",
"expiry": "2026-10-16",
"implied_volatility": "0.4205005180971295",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "21600.00",
"price": "10.80",
"open_interest": 503,
"nbbo_ask": "11.90",
"size": 20,
"delta": "0.527488756979546",
"volume": 80,
"option_type": "call",
"nbbo_bid": "10.20",
"option_chain_id": "CRL261016C00290000",
"executed_at": "2026-09-29T15:06:59.138000Z",
"strike": "290",
"underlying_price": "290.075",
"expiry": "2026-10-16",
"implied_volatility": "0.4205005180971295",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "20340.00",
"price": "11.30",
"open_interest": 503,
"nbbo_ask": "11.30",
"size": 18,
"delta": "0.528552162853158",
"volume": 20,
"option_type": "call",
"nbbo_bid": "10.20",
"option_chain_id": "CRL261016C00290000",
"executed_at": "2026-09-29T14:58:08.158000Z",
"strike": "290",
"underlying_price": "290.12",
"expiry": "2026-10-16",
"implied_volatility": "0.4396151590619231",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "16800.00",
"price": "11.20",
"open_interest": 503,
"nbbo_ask": "11.90",
"size": 15,
"delta": "0.5343888881953",
"volume": 60,
"option_type": "call",
"nbbo_bid": "10.20",
"option_chain_id": "CRL261016C00290000",
"executed_at": "2026-09-29T15:01:56.149000Z",
"strike": "290",
"underlying_price": "290.53",
"expiry": "2026-10-16",
"implied_volatility": "0.4268578055937888",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "12700.00",
"price": "12.70",
"open_interest": 503,
"nbbo_ask": "12.70",
"size": 10,
"delta": "0.577642186989777",
"volume": 110,
"option_type": "call",
"nbbo_bid": "11.80",
"option_chain_id": "CRL261016C00290000",
"executed_at": "2026-09-29T19:00:31.140000Z",
"strike": "290",
"underlying_price": "293.445",
"expiry": "2026-10-16",
"implied_volatility": "0.4220017305015247",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "11079.00",
"price": "110.79",
"open_interest": 2,
"nbbo_ask": "112.80",
"size": 1,
"delta": "0.989876195135709",
"volume": 1,
"option_type": "call",
"nbbo_bid": "109.40",
"option_chain_id": "CRL261016C00180000",
"executed_at": "2026-09-29T14:36:49.519000Z",
"strike": "180",
"underlying_price": "290.22",
"expiry": "2026-10-16",
"implied_volatility": "1.003944250805614",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "10700.00",
"price": "21.40",
"open_interest": 143,
"nbbo_ask": "22.10",
"size": 5,
"delta": "0.511385821008699",
"volume": 34,
"option_type": "call",
"nbbo_bid": "21.40",
"option_chain_id": "CRL261120C00300000",
"executed_at": "2026-09-29T18:47:34.976000Z",
"strike": "300",
"underlying_price": "294.05",
"expiry": "2026-11-20",
"implied_volatility": "0.526119649667196",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "10700.00",
"price": "21.40",
"open_interest": 143,
"nbbo_ask": "22.10",
"size": 5,
"delta": "0.511385821008699",
"volume": 21,
"option_type": "call",
"nbbo_bid": "21.40",
"option_chain_id": "CRL261120C00300000",
"executed_at": "2026-09-29T18:47:34.976000Z",
"strike": "300",
"underlying_price": "294.05",
"expiry": "2026-11-20",
"implied_volatility": "0.526119649667196",
"sector": "Healthcare"
},
{
"underlying_symbol": "CRL",
"premium": "10700.00",
"price": "21.40",
"open_interest": 143,
"nbbo_ask": "22.10",
"size": 5,
"delta": "0.511385821008699",
"volume": 14,
"option_type": "call",
"nbbo_bid": "21.40",
"option_chain_id": "CRL261120C00300000",
"executed_at": "2026-09-29T18:47:34.975000Z",
"strike": "300",
"underlying_price": "294.05",
"expiry": "2026-11-20",
"implied_volatility": "0.526119649667196",
"sector": "Healthcare"
}
],
"net_premium": {
"ticker": "CRL",
"net_call_premium": "1315.00",
"net_put_premium": "-153375.00",
"call_premium": "233368.00",
"put_premium": "240945.00",
"bullish_premium": "312874.00",
"bearish_premium": "158184.00",
"put_call_ratio": "1.2569832402234636871508379888",
"iv_rank": "40.8715",
"implied_move_perc": "0.097",
"gex_ratio": "0.35383133137936727700",
"gex_net_change": "136.5587",
"gex_call": "3129.7359",
"gex_put": "-1252.5422",
"gex_net": 1877.1937,
"gex_call_delta": "298709.7016",
"gex_put_delta": "-40415.7760",
"gex_date": "2026-09-30"
},
"hot_chains": [
{
"open_interest": 503,
"volume": 110,
"last_price": "12.70",
"option_symbol": "CRL261016C00290000",
"ask_volume": 70,
"bid_volume": 40,
"nbbo_bid": "13.40",
"nbbo_ask": "15.20",
"avg_price": "11.210909090909090909090909090"
},
{
"open_interest": 7,
"volume": 70,
"last_price": "12.60",
"option_symbol": "CRL261120P00270000",
"ask_volume": 2,
"bid_volume": 68,
"nbbo_bid": "11.00",
"nbbo_ask": "12.10",
"avg_price": "12.602857142857142857142857143"
},
{
"open_interest": 3,
"volume": 64,
"last_price": "2.25",
"option_symbol": "CRL261120P00220000",
"ask_volume": 3,
"bid_volume": 61,
"nbbo_bid": "1.65",
"nbbo_ask": "2.90",
"avg_price": "2.2500000000000000000000000000"
},
{
"open_interest": 30,
"volume": 53,
"last_price": "16.70",
"option_symbol": "CRL261120P00280000",
"ask_volume": 2,
"bid_volume": 51,
"nbbo_bid": "14.80",
"nbbo_ask": "16.40",
"avg_price": "16.700000000000000000000000000"
},
{
"open_interest": 143,
"volume": 36,
"last_price": "21.74",
"option_symbol": "CRL261120C00300000",
"ask_volume": 10,
"bid_volume": 26,
"nbbo_bid": "20.80",
"nbbo_ask": "23.30",
"avg_price": "21.123333333333333333333333332"
},
{
"open_interest": 2,
"volume": 11,
"last_price": "2.85",
"option_symbol": "CRL261120C00380000",
"ask_volume": 11,
"bid_volume": 0,
"nbbo_bid": "2.15",
"nbbo_ask": "5.10",
"avg_price": "2.8500000000000000000000000000"
},
{
"open_interest": 66,
"volume": 10,
"last_price": "20.65",
"option_symbol": "CRL261120P00290000",
"ask_volume": 9,
"bid_volume": 1,
"nbbo_bid": "19.10",
"nbbo_ask": "20.40",
"avg_price": "21.865000000000000000000000000"
},
{
"open_interest": 249,
"volume": 5,
"last_price": "9.00",
"option_symbol": "CRL261016P00290000",
"ask_volume": 5,
"bid_volume": 0,
"nbbo_bid": "6.60",
"nbbo_ask": "9.10",
"avg_price": "9.140000000000000000000000000"
}
],
"gamma_profile": {
"ticker": "CRL",
"spot": 299.0,
"date": "2026-09-30",
"flip_point": 161.12,
"net_gex": 1877.19,
"call_walls": [
{
"strike": 320.0,
"gex": 727.63
},
{
"strike": 290.0,
"gex": 621.38
},
{
"strike": 280.0,
"gex": 350.23
}
],
"put_walls": [
{
"strike": 270.0,
"gex": -420.84
},
{
"strike": 290.0,
"gex": -405.92
},
{
"strike": 300.0,
"gex": -112.15
}
],
"by_strike": [
{
"strike": 190.0,
"call_gex": 1.03,
"put_gex": -3.0,
"net_gex": -1.97
},
{
"strike": 195.0,
"call_gex": 1.74,
"put_gex": -1.45,
"net_gex": 0.29
},
{
"strike": 200.0,
"call_gex": 7.25,
"put_gex": -2.58,
"net_gex": 4.68
},
{
"strike": 210.0,
"call_gex": 14.98,
"put_gex": -4.25,
"net_gex": 10.73
},
{
"strike": 220.0,
"call_gex": 29.59,
"put_gex": -21.09,
"net_gex": 8.49
},
{
"strike": 230.0,
"call_gex": 207.34,
"put_gex": -4.07,
"net_gex": 203.27
},
{
"strike": 240.0,
"call_gex": 67.79,
"put_gex": -35.68,
"net_gex": 32.11
},
{
"strike": 250.0,
"call_gex": 75.07,
"put_gex": -17.85,
"net_gex": 57.22
},
{
"strike": 260.0,
"call_gex": 107.2,
"put_gex": -42.28,
"net_gex": 64.91
},
{
"strike": 270.0,
"call_gex": 82.36,
"put_gex": -420.84,
"net_gex": -338.48
},
{
"strike": 280.0,
"call_gex": 350.23,
"put_gex": -104.36,
"net_gex": 245.87
},
{
"strike": 290.0,
"call_gex": 621.38,
"put_gex": -405.92,
"net_gex": 215.47
},
{
"strike": 300.0,
"call_gex": 282.03,
"put_gex": -112.15,
"net_gex": 169.88
},
{
"strike": 310.0,
"call_gex": 255.41,
"put_gex": -7.22,
"net_gex": 248.18
},
{
"strike": 320.0,
"call_gex": 727.63,
"put_gex": -61.4,
"net_gex": 666.23
},
{
"strike": 330.0,
"call_gex": 166.03,
"put_gex": -0.8,
"net_gex": 165.24
},
{
"strike": 340.0,
"call_gex": 17.29,
"put_gex": -0.54,
"net_gex": 16.75
},
{
"strike": 350.0,
"call_gex": 37.16,
"put_gex": 0.0,
"net_gex": 37.16
},
{
"strike": 360.0,
"call_gex": 8.73,
"put_gex": 0.0,
"net_gex": 8.73
},
{
"strike": 370.0,
"call_gex": 21.23,
"put_gex": -0.4,
"net_gex": 20.83
},
{
"strike": 380.0,
"call_gex": 19.59,
"put_gex": 0.0,
"net_gex": 19.59
},
{
"strike": 390.0,
"call_gex": 1.0,
"put_gex": 0.0,
"net_gex": 1.0
},
{
"strike": 400.0,
"call_gex": 0.89,
"put_gex": -0.2,
"net_gex": 0.69
},
{
"strike": 410.0,
"call_gex": 1.46,
"put_gex": 0.0,
"net_gex": 1.46
},
{
"strike": 420.0,
"call_gex": 2.65,
"put_gex": 0.0,
"net_gex": 2.65
}
]
},
"oi_changes": {
"net_call_oi_change": 1,
"net_put_oi_change": 1,
"top": [
{
"strike": null,
"oi_change": 1,
"type": "put"
},
{
"strike": null,
"oi_change": 1,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": -3.5,
"D": -12.0,
"P": 40.3,
"O": 16.4,
"C": 29.4,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": 16.7,
"T": 68.2,
"RS": 84.4,
"V": 2.4,
"F": 48.4,
"OI": 0.0,
"S": null,
"IV": 12.3,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": 0.0,
"FlowAgreement": 100.0,
"StrikeBreadth": 50.0
},
"drivers": [
"+ relative strength +84",
"+ trend +68",
"+ aggressive flow +48"
]
}
}
Data:
{
"vix": 15.67,
"sp500": 7743.41,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.36,
"hy_spread": 2.8,
"treasury": {
"date": "2026-09-28",
"month1": 4.04,
"month2": 4.2,
"month3": 4.28,
"month6": 4.41,
"year1": 4.59,
"year2": 4.92,
"year3": 5.01,
"year5": 5.06,
"year7": 5.15,
"year10": 5.24,
"year20": 5.6,
"year30": 5.56
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.2%",
"actual": null,
"minutes_until": -8
},
{
"title": "Final GDP q/q",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": -8
},
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 2871
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "90K",
"previous": "162K",
"actual": null,
"minutes_until": 2871
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 2871
}
]
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 98,
"pct": 95
},
{
"name": "Woodie Pivot Touch",
"count": 98,
"pct": 95
},
{
"name": "PDH/PDL Touch",
"count": 89,
"pct": 86
},
{
"name": "Open Retracement",
"count": 78,
"pct": 76
},
{
"name": "Gap Fill",
"count": 77,
"pct": 75
},
{
"name": "Darvas Box",
"count": 35,
"pct": 34
},
{
"name": "High Vol Open",
"count": 29,
"pct": 28
},
{
"name": "Power Hour",
"count": 10,
"pct": 10
}
]
}